Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2012
11/06/2012US8304453 Composition comprising at least one alkanolamide to inhibit migration of langerhans cells and uses therof
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012US8304407 8-substituted benzoazepines as toll-like receptor modulators
11/06/2012US8304405 Combination of azelastine and ciclesonide for nasal administration
11/06/2012US8303958 Method of treating immunological disorders by administering truncated BAFF receptors
11/06/2012CA2545359C Compositions and methods for regulation of tumor necrosis factor-alpha
11/06/2012CA2494379C Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
11/01/2012WO2012149557A1 miR-33 INHIBITORS AND USES THEREOF TO DECREASE INFLAMMATION
11/01/2012WO2012149381A1 Compositions and methods for improving night vision
11/01/2012WO2012149268A1 Tolerogenic synthetic nanocarriers for allergy therapy
11/01/2012WO2012149259A1 Tolerogenic synthetic nanocarriers to reduce antibody responses
11/01/2012WO2012149228A1 Compositions and method for treating autoimmune diseases
11/01/2012WO2012147916A1 Amide compound and pharmaceutical application therefor
11/01/2012WO2012147705A1 Therapeutic agent for inflammatory respiratory diseases comprising trehalose
11/01/2012US20120277288 Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
11/01/2012US20120277279 Non-Steroidal Glucocorticoid Inhibitors and Their Use in Treating Inflammation, Allergy and Auto-Immune Conditions
11/01/2012US20120277275 Azole and thiazole derivatives and their use
11/01/2012US20120277259 Substituted benzofused derivatives and their use as vanilloid receptor ligands
11/01/2012US20120277255 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277248 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
11/01/2012US20120277247 Novel compound useful for the treatment of degenerative and inflammatory diseases
11/01/2012US20120277240 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
11/01/2012US20120277238 Pharmaceutical composition containing fused hetero-ring derivative
11/01/2012US20120277227 Benzimidazole inhibitors of leukotriene production
11/01/2012US20120277226 Benzimidazole inhibitors of leukotriene production
11/01/2012US20120277219 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/01/2012US20120277217 Imidazole Derivatives as IDO Inhibitors
11/01/2012US20120277214 Tricyclopyrazole derivatives
11/01/2012US20120277210 Solid dispersions containing an apoptosis-inducing agent
11/01/2012US20120277205 Derivatives of n-[(1h-pyrazol-1-yl)aryl]-1h-indole or 1h-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics
11/01/2012US20120277199 Modulation of Gel Temperature of Poloxamer-Containing Formulations
11/01/2012US20120277198 Polyhydroxylated bile acids for treatment of biliary disorders
11/01/2012US20120277194 Aminopropanol derivatives
11/01/2012US20120277182 Anoectochilus spp. polysaccharide extracts for stimulating growth of advantageous bacteria, stimulating release of granulocyte colony-stimulating factor, modulating t helper cell type i, and/or modulating t helper cell type ii and uses of the same
11/01/2012US20120277174 New macrolides and their use
11/01/2012US20120277146 Compounds For Enzyme Inhibition
11/01/2012US20120276216 Therapeutic Water Treatment
11/01/2012US20120276215 Therapeutic Conditioned Media
11/01/2012US20120276213 Method for enzymatic treatment of tissue products
11/01/2012US20120276201 Compositions and method for treatment and prophylaxis of inflammatory bowel disease
11/01/2012US20120276193 Agents, Uses and Methods
11/01/2012US20120276192 Compositions and methods for sirna inhibition of icam-1
11/01/2012US20120276191 Treatment and Diagnosis of Macrophage Mediated Disease
11/01/2012US20120276160 Tolerogenic synthetic nanocarriers for regulating innate immune responses
11/01/2012US20120276159 Tolerogenic synthetic nanocarriers
11/01/2012US20120276158 Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses
11/01/2012US20120276157 Tolerogenic synthetic nanocarriers to reduce antibody responses
11/01/2012US20120276156 Tolerogenic synthetic nanocarrier compositions with transplantable graft antigens and methods of use
11/01/2012US20120276155 Tolerogenic synthetic nanocarriers for generating cd8+ regulatory t cells
11/01/2012US20120276153 Use of aerosolized levofloxacin for treating cystic fibrosis
11/01/2012US20120276149 Methods for modulating bacterial infection
11/01/2012US20120276148 Adenoviral vector vaccine
11/01/2012US20120276147 Ctsp cancer-testis antigens
11/01/2012US20120276146 Vaccine against cholera and enterotoxigenic e. coli (etec) diarrhea
11/01/2012US20120276145 Extracellular matrix proteins from haemophilus influenzae biofilms: targets for therapeutic or diagnostic use
11/01/2012US20120276144 Pro-Apoptotic Bacterial Vaccines To Enhance Cellular Immune Responses
11/01/2012US20120276143 Probiotic bifidobacterium strain
11/01/2012US20120276142 Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same
11/01/2012US20120276141 Env polypeptide complexes and methods of use
11/01/2012US20120276140 Compositions and methods for activating innate and allergic immunity
11/01/2012US20120276139 Use of newcastle disease virus-based vector for inducing an immune response in mammals
11/01/2012US20120276138 Rapid and prolonged immunologic-therapeutic
11/01/2012US20120276137 Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
11/01/2012US20120276136 Chemically programmable immunity
11/01/2012US20120276135 Methods for improving the design, bioavailability, and efficacy of random sequence polymer compositions via serum protein-based detection of random sequence polymer compositions
11/01/2012US20120276134 Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cells
11/01/2012US20120276133 Tolerogenic synthetic nanocarriers for inducing regulatory b cells
11/01/2012US20120276132 Atoxic recombinant holotoxins of Clostridium difficile as immunogens
11/01/2012US20120276131 Anti-trypanosomiasis vaccines and diagnostics
11/01/2012US20120276130 Diagnostic and therapeutic methods for rheumatic heart disease based upon group a streptococcus markers
11/01/2012US20120276129 Neisserial antigenic peptides
11/01/2012US20120276128 HIV Envelope-CD4 Complexes and Hybrids
11/01/2012US20120276126 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/01/2012US20120276125 Novel immunoconjugates
11/01/2012US20120276120 T-Cell Stimulating Protein B and Methods of Use
11/01/2012US20120276117 Binding Partners for the Thyrotropin Receptor and Uses Thereof
11/01/2012US20120276111 Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap-1) inhibitor
11/01/2012US20120276110 Modulation of Pathogenic Monocytes
11/01/2012US20120276109 Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
11/01/2012US20120276108 Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases
11/01/2012US20120276107 Methods and Compositions for Mycoplasma Pneumoniae Exotoxins
11/01/2012US20120276102 Methods of treatment utiliziing binding proteins of the interleukin-21 receptor
11/01/2012US20120276101 Viral chemokine-antigen fusion proteins
11/01/2012US20120276100 Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
11/01/2012US20120276090 Gene recombinant antibody and antibody fragment thereof
11/01/2012US20120276086 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues
11/01/2012US20120276075 Synergic action of a prolyl protease and tripeptidyl proteases
11/01/2012US20120276074 Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
11/01/2012US20120276061 CD117+ Cells and Uses Thereof
11/01/2012US20120276049 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
11/01/2012US20120276047 Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
11/01/2012US20120276045 Treatment of solid cancers
11/01/2012US20120275996 IL-1 Binding Proteins
11/01/2012CA2837367A1 Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection
11/01/2012CA2834626A1 Therapeutic nuclease compositions and methods
11/01/2012CA2834599A1 Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cells
11/01/2012CA2834533A1 Tolerogenic synthetic nanocarriers for allergy therapy
11/01/2012CA2834527A1 Tolerogenic synthetic nanocarriers to reduce antibody responses
11/01/2012CA2834349A1 Liposomal formulations
11/01/2012CA2834203A1 Compositions and method for treating autoimmune diseases
1 ... 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 ... 1172